Division of International Strategy International Collaborative Research Program: The e-ASIA Joint Research Program (e-ASIA JRP)

Outline

Key Fields Innovation and Clinical Research Center Project, Cancer, Infectious disease, Other programs(1st)
R&D phase Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Trials, Clinical Research
Contact
Office of International Collaboration, Division of International Strategy, Department of International Strategy, AMED
TEL: +81-3-6870-2216
E-mail: e-asia”at”amed.go.jp(Replace “at” with @)

The e-ASIA Joint Research Program (hereinafter referred to as the “e-ASIA JRP”) aims to develop a vibrant and collaborative research community in Science and Technology, to promote innovation in the East Asian region, and to contribute to the region’s economic development.

fig01
Current Member Organizations

Ongoing Projects

Year Project Title Principal Investigator Affiliation Country
2017-2021 A study of latitudinal viral gene migration and reassortment of potentially zoonotic avian influenza viruses along wild bird East Asian - Australasian Flyway in Pacific Rim SAKODA Yoshihiro (Professor) Hokkaido University, Graduate School of Veterinary Medicine Japan
Alexander Shestopalov (Professor) Research institute of experimental and clinical medicine Russia
Duc-Huy Chu (Veterinary Officer) Department of Animal Health, Epidemiology division Vietnam
Falk Huettmann (Associate Professor) Institute of Arctic Biology, Biology & Wildlife Department U.S.
2017-2021 Surveillance of specific cancer incidence and mortality in South East Asia, by developing a standard population-based cancer registry system MATSUDA Tomohiro (Section Head) National Cancer Center, Center for Cancer Registries Japan
Hav Monirath (Head of Department) Calmette Hospital, Department of Pathology Cambodia
Adriano Laudico (Project Director) Philippine Cancer Society Inc., Manila Cancer Registry Philippines
Dung Pham Xuan (Director) Ho Chi Minh City Oncological Hospital Vietnam
2017-2021 Elucidating the contribution of HBV/HDV co-/super-infection to hepatocellular carcinoma genome and biology YAMASHITA Taro (Associate Professor) Kanazawa University, Hospital / General Medicine Japan
Xin Wei Wang (Chief) National Cancer Institute, Laboratory of Human Carcinogenesis U.S.
Pham Van Thuc (Professor) Haiphong University of Medical and Pharmacy, Medical and Pharmacy Vietnam
2018-2021 Development of new diagnostic tools for detecting malaria parasites resistant to drugs used in Artermisinin-based combination therapy IWANAGA Shiroh (Professor) Osaka University Japan
Chairat Uthaipibull (Principal Researcher) National Center for Genetic Engineering and Biotechnology (BIOTEC) Thailand
Din Syafruddin (Professor) Eijkman Institute for Molecular Biology Indonesia
2018-2021 Construction of liver fluke biliary cancer PDX library aiming at development of personalized medicine Siwanon Jirawatnotai (Associate Professor)  Mahidol University Thailand
OKADA Seiji  (Professor) Kumamoto University Japan
Piotr Sicinski (Professor) Dana-Farber Cancer Institute U.S.
2019-2022 Integrative Application of Human and Pathogen Genomic Information for improvement of treatment outcome and control of drug-resistance in Asian tuberculosis patients TOKUNAGA Katsushi (Director) National Center for Global Health and Medicine (NCGM) Japan
Surakameth Mahasirimongkol (Senior Physician) Department of Medical Sciences, Ministry of Public Health Thailand
Rika Yuliwukandari (Dean) Yarsi University Indonesia
Mari Rose De Los Reyes (Head) Research Institute for Tropical Medicine Philippines
2019-2022 An international platform for discovery of novel chemotypes against flaviviral infection SAKAI Ryuichi (Professor) Hokkaido University Japan
Sarin Chimnaronk (Assistant Professor) Mahidol University Thailand
Daniel Romo (Professor) Baylor University U.S.
2019-2022 The Predict-XDR Project: Predicting genetic markers for pre-XDR and XDR tuberculosis MITARAI Satoshi (Professor, Head) The Research Institute of Tuberculosis Japan
KATO-MAEDA Midori (Associate Professor) University of California San Francisco U.S.
Raul V. Destura (Deputy Executive Director) University of the Philippines Philippines
2020-2023 Identification of molecular and cellular pathways predicting susceptibility or
resistance to severe dengue fever
Diana Hansen
(Laboratory Head)
The Walter Eliza Hall Institute of Medical Research Australia
Sasumono Tedjo
(Laboratory Head)
Eijkman Institute for Molecular Biology Indonesia
MORITA Kouichi
(Professor, Dean)
Nagasaki University Japan
2020-2023 Novel precision-based treatments for biliary tract cancer John Mariadason
(Professor)
La Trobe University Australia
Temduang Limpaiboon
(Professor)
Khon Kaen University Thailand
SAITO Yoshimasa
(Professor)
Keio University Japan

Results Report

Management and Evaluation Framework

PS (Program Supervisor)
  • WATANABE Haruo, M.D., Ph.D., Honorary member, National Institute of Infectious Diseases / Chairperson of the board of trustees, KUROZUMI Medical FoundationHaruo
PO (Program Officer)
  • KITA Kiyoshi, Ph.D., Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University
  • KIYONO Tohru, M.D.,Ph.D., Project Leader, Project for Prevention of HPV-related cancer, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center

Brochure

Last updated 2021.5.31